A 0 1 0 1 O
diagnosis 2 11 2 11 O
of 12 14 12 14 O
proximal 15 23 15 23 O
DVT 24 27 24 27 O
( 28 29 28 29 O
proximal 29 37 29 37 O
to 38 40 38 40 O
and 41 44 41 44 O
including 45 54 45 54 O
popliteal 55 64 55 64 O
vein 65 69 65 69 O
) 69 70 69 70 O
, 70 71 70 71 O
with 72 76 72 76 O
or 77 79 77 79 O
without 80 87 80 87 O
PE 88 90 88 90 B-chronic_disease
, 90 91 90 91 O
confirmed 92 101 92 101 O
by 102 104 102 104 O
objective 105 114 105 114 O
imaging 115 122 115 122 O
studies 123 130 123 130 O
, 130 131 130 131 O
such 132 136 132 136 O
as 137 139 137 139 O
Doppler 140 147 140 147 B-treatment
ultrasound 148 158 148 158 I-treatment
, 158 159 158 159 O
venograms 160 169 160 169 B-treatment
( 170 171 170 171 O
for 171 174 171 174 O
DVT 175 178 175 178 O
) 178 179 178 179 O
and/or 180 186 180 186 O
computer 187 195 187 195 B-treatment
tomography 196 206 196 206 I-treatment
, 206 207 206 207 O
angiograms 208 218 208 218 B-treatment
, 218 219 218 219 O
ventilation 220 231 220 231 B-treatment
- 231 232 231 232 I-treatment
perfusion 232 241 232 241 I-treatment
scan 242 246 242 246 I-treatment
( 247 248 247 248 O
for 248 251 248 251 O
PE 252 254 252 254 O
) 254 255 254 255 O

Any 0 3 256 259 O
malignancy 4 14 260 270 B-cancer
diagnosed 15 24 271 280 O
within 25 31 281 287 O
the 32 35 288 291 O
preceding 36 45 292 301 O
2 46 47 302 303 B-upper_bound
years 48 53 304 309 I-upper_bound
, 53 54 309 310 O
except 55 61 311 317 O
for 62 65 318 321 O
squamous 66 74 322 330 B-cancer
cell 75 79 331 335 I-cancer
carcinoma 80 89 336 345 I-cancer
or 90 92 346 348 O
basal 93 98 349 354 B-cancer
cell 99 103 355 359 I-cancer
carcinoma 104 113 360 369 I-cancer
of 114 116 370 372 I-cancer
skin 117 121 373 377 I-cancer
treated 122 129 378 385 O
with 130 134 386 390 O
local 135 140 391 396 B-treatment
resection 141 150 397 406 I-treatment
only 151 155 407 411 O
, 155 156 411 412 O
or 157 159 413 415 O
carcinoma 160 169 416 425 B-cancer
in 170 172 426 428 I-cancer
situ 173 177 429 433 I-cancer
of 178 180 434 436 I-cancer
the 181 184 437 440 I-cancer
cervix 185 191 441 447 I-cancer

At 0 2 448 450 O
least 3 8 451 456 O
18 9 11 457 459 B-lower_bound
years 12 17 460 465 I-lower_bound
old 18 21 466 469 O

Patients 0 8 470 478 O
with 9 13 479 483 O
baseline 14 22 484 492 B-clinical_variable
aspartate 23 32 493 502 I-clinical_variable
aminotransferase 33 49 503 519 I-clinical_variable
( 50 51 520 521 I-clinical_variable
AST 51 54 521 524 I-clinical_variable
) 54 55 524 525 I-clinical_variable
, 55 56 525 526 O
alanine 57 64 527 534 B-clinical_variable
aminotransferase 65 81 535 551 I-clinical_variable
( 82 83 552 553 I-clinical_variable
ALT 83 86 553 556 I-clinical_variable
) 86 87 556 557 I-clinical_variable
, 87 88 557 558 O
or 89 91 559 561 O
total 92 97 562 567 B-clinical_variable
bilirubin 98 107 568 577 I-clinical_variable
â‰¥2.0 108 112 578 582 O
x 113 114 583 584 I-lower_bound
ULN 115 118 585 588 I-lower_bound
( 119 120 589 590 I-lower_bound
upper 120 125 590 595 I-lower_bound
limit 126 131 596 601 I-lower_bound
of 132 134 602 604 I-lower_bound
normal 135 141 605 611 I-lower_bound
) 141 142 611 612 I-lower_bound

Patients 0 8 613 621 O
with 9 13 622 626 O
statin 14 20 627 633 B-treatment
use 21 24 634 637 O
within 25 31 638 644 O
6 32 33 645 646 B-upper_bound
weeks 34 39 647 652 I-upper_bound
of 40 42 653 655 O
enrollment 43 53 656 666 O

Pregnant 0 8 667 675 B-pregnancy

Thrombolysis 0 12 676 688 B-treatment
within 13 19 689 695 O
6 20 21 696 697 B-upper_bound
weeks 22 27 698 703 I-upper_bound
prior 28 33 704 709 I-upper_bound
to 34 36 710 712 O
enrollment 37 47 713 723 O

Treated 0 7 724 731 O
with 8 12 732 736 O
warfarin 13 21 737 745 B-treatment
as 22 24 746 748 O
anticoagulation 25 40 749 764 B-treatment

breastfeeding 0 13 765 778 O
females 14 21 779 786 B-gender

short 0 5 787 792 O
- 5 6 792 793 O
term 6 10 793 797 O
bridging 11 19 798 806 O
with 20 24 807 811 O
heparin 25 32 812 819 B-treatment
or 33 35 820 822 O
lovenox 36 43 823 830 B-treatment

